.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
US Army
Teva
Covington
Express Scripts
Citi
Chinese Patent Office
Farmers Insurance
AstraZeneca
Fuji

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060456

« Back to Dashboard
NDA 060456 describes PENICILLIN-VK, which is a drug marketed by Teva and is included in two NDAs. It is available from seven suppliers. Additional details are available on the PENICILLIN-VK profile page.

The generic ingredient in PENICILLIN-VK is penicillin v potassium. There are eighty-seven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

Summary for NDA: 060456

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 060456

Ingredient-typePenicillins

Suppliers and Packaging for NDA: 060456

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PENICILLIN-VK
penicillin v potassium
FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA Inc 0093-4125 0093-4125-73 100 mL in 1 BOTTLE (0093-4125-73)
PENICILLIN-VK
penicillin v potassium
FOR SOLUTION;ORAL 060456 ANDA Teva Pharmaceuticals USA Inc 0093-4125 0093-4125-74 200 mL in 1 BOTTLE (0093-4125-74)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrengthEQ 125MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrengthEQ 250MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Teva
Queensland Health
Express Scripts
Mallinckrodt
US Department of Justice
QuintilesIMS
Moodys
Healthtrust
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot